Richmond Mutual Bancorporation, Inc.
NASDAQ:RMBIBanks - Regional
+$0.05 today
- Market cap
- $254.52M
- Beta
- 0.32
- P/E (TTM)
- 11.5
- EPS (TTM)
- $1.28
- Dividend yield
- 4.07%
Volume 0.06M
Average 0.04M
RMBI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Richmond Mutual Bancorporation, Inc.NASDAQ: RMBI
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How RMBI compares with its peers on the latest reported figures
- RMBI's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for RMBI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding RMBI) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for RMBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 51.21M | 56.59M | 71.82M | 85.05M | 90.89M |
| Cost of Revenue | 9.11M | 10.82M | 30.28M | 42.37M | 43.81M |
| Gross Profit | 42.1M | 45.77M | 41.54M | 42.68M | 47.04M |
| Gross Margin | 82.2% | 80.9% | 57.8% | 50.2% | 51.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 19.01M | 19.43M | 18.99M | 20.26M | 15.2M |
| Operating Expenses | 28.52M | 30.02M | 30.53M | 31.82M | 32.98M |
| Depreciation & Amortization | 1.54M | 1.29M | 1.19M | 1.04M | 818.24K |
| EBITDA | 15.12M | 17.04M | 12.19M | 11.91M | 14.88M |
| EBITDA Margin | 29.5% | 30.1% | 17.0% | 14.0% | 16.4% |
| Operating Income | 13.58M | 15.75M | 11M | 10.86M | 14.06M |
| Operating Margin | 26.5% | 27.8% | 15.3% | 12.8% | 15.5% |
| Interest Income | 45.93M | 51.86M | 67.41M | 80.53M | 85.91M |
| Interest Expense | 7.68M | 10.22M | 29.75M | 41.82M | 42.06M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (409K) |
| Income Before Tax | 13.58M | 15.75M | 11M | 10.86M | 13.65M |
| Pre-Tax Margin | 26.5% | 27.8% | 15.3% | 12.8% | 15.0% |
| Income Tax Expense | 2.44M | 2.78M | 1.52M | 1.49M | 2.08M |
| Net Income | 11.15M | 12.97M | 9.49M | 9.38M | 11.58M |
| Net Margin | 21.8% | 22.9% | 13.2% | 11.0% | 12.7% |
| EPS (Basic) | 0.98 | 1.20 | 0.91 | 0.93 | 1.20 |
| EPS (Diluted) | 0.96 | 1.17 | 0.91 | 0.92 | 1.17 |
| Weighted Avg Shares | 11.36M | 10.77M | 10.4M | 10.08M | 9.66M |
| Weighted Avg Shares (Diluted) | 11.63M | 11.06M | 10.45M | 10.23M | 9.83M |
Richmond Mutual Bancorporation, Inc.
NASDAQ:RMBI
Intrinsic Alpha fair value
Locked
Current Price
$15.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.